Trastuzumab-related subclinical cardiotoxicity in patients with early stage HER2-positive breast cancer: A retrospective single-center cohort study.

被引:0
|
作者
Aseyev, Olexiy
Rushton-Marovac, Moira
Crawley, Freya L.
Johnson, Christopher
Dent, Susan Faye
机构
关键词
D O I
10.1200/JCO.2017.35.15_suppl.10123
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10123
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Cardiotoxicity in HER2-positive breast cancer patients
    Diana Gonciar
    Lucian Mocan
    Alexandru Zlibut
    Teodora Mocan
    Lucia Agoston-Coldea
    Heart Failure Reviews, 2021, 26 : 919 - 935
  • [22] Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Yu, Anthony F.
    Yadav, Nandini U.
    Lung, Betty Y.
    Eaton, Anne A.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (02) : 489 - 495
  • [23] Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study
    Chen, Xiaobin
    Cai, Qindong
    Deng, Lin
    Chen, Minyan
    Xu, Min
    Chen, Lili
    Lin, Yuxiang
    Li, Yan
    Wang, Yali
    Chen, Hanxi
    Liu, Shunyi
    Wu, Jinqiao
    Tong, Xin
    Fu, Fangmeng
    Wang, Chuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Retrospective single-center outcome analysis of neoadjuvant and palliative treatment with dual trastuzumab and pertuzumab in HER2-positive breast cancer.
    Marhold, Maximilian
    Ionce, Lea Roxana
    Christ, Alexandra
    Aretin, Marie-Bernadette
    Sagaster, Verena
    Exner, Ruth
    Wimmer, Kerstin
    Devyatko, Yelena
    Fitzal, Florian
    Steger, Guenther G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Comparing trastuzumab-related cardiotoxicity between elderly and younger patients with breast cancer: a prospective cohort study
    Aladwani, A.
    Mullen, A.
    Alrashidi, M.
    Alfarisi, O.
    Alterkait, F.
    Kumar, A.
    Boyd, M.
    Eldosouky, M. E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 7643 - 7653
  • [26] Trastuzumab-induced cardiotoxicity in Uruguayan HER2-positive breast cancer patients.
    Schiavone, Andrea
    Diaz, Mariana
    Camejo, Natalia
    Reborido, Natalia
    Vazquez, Horacio
    Parma, Gabriel
    Vazquez, Alvaro
    Castillo, Cecilia
    Krygier, Gabriel David
    Delgado, Lucia Beatriz
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [27] Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients
    Yamshiro, Hiroyasu
    Iwata, Hiroji
    Masuda, Norikazu
    Yamamoto, Naohito
    Nishimura, Reiki
    Ohtani, Shoichiro
    Sato, Nobuki
    Takahashi, Masato
    Kamio, Takako
    Yamazaki, Kosuke
    Saito, Tsuyoshi
    Kato, Makoto
    Lee, Tecchuu
    Ohno, Shinji
    Kuroi, Katsumasa
    Takano, Toshimi
    Takada, Masahiro
    Yasuno, Shinji
    Morita, Satoshi
    Toi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 709 - 722
  • [28] Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients
    Hiroyasu Yamshiro
    Hiroji Iwata
    Norikazu Masuda
    Naohito Yamamoto
    Reiki Nishimura
    Shoichiro Ohtani
    Nobuki Sato
    Masato Takahashi
    Takako Kamio
    Kosuke Yamazaki
    Tsuyoshi Saito
    Makoto Kato
    Tecchuu Lee
    Shinji Ohno
    Katsumasa Kuroi
    Toshimi Takano
    Masahiro Takada
    Shinji Yasuno
    Satoshi Morita
    Masakazu Toi
    International Journal of Clinical Oncology, 2015, 20 : 709 - 722
  • [29] A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
    Ben Kridis, Wala
    Sghaier, Syrine
    Charfeddine, Salma
    Toumi, Nabil
    Daoud, Jamel
    Kammoun, Samir
    Khanfir, Afef
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (07): : 510 - 516
  • [30] Tracking Trastuzumab (H) Therapy in Early Through Late Stage HER2-Positive Breast Cancer (HER2BC) in Australia: A National, Retrospective Cohort Study
    Daniels, Benjamin
    Pearson, Sallie-Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 521 - 521